NCT05706727

Brief Summary

Hemodynamics changes with spinal anesthesia is mainly due to sympathetic block which causes mainly hypotension \& bradycardia. Post spinal hypotension usually leads to various adverse maternal and fetal outcomes. Hence, effective prevention and treatment of maternal hypotension is of great clinical significance. Various studies have been done for the prevention of subarachnoid block induced hypotension but the optimal choice of vasopressors for the maintenance of hemodynamic stability during cesarean under spinal anesthesia is still unclear. The ideal vasopressor would be the one which is reliable and easy to use , has rapid onset, short duration of action, easily tritatable, can potentially be used prophylactically and lack any adverse maternal and fetal impact. Thus, aim of study is to compare the hemodynamic stability of mephenterime and phenylephrine during elective cesarean section under spinal anesthesia. The methodology of the study will be prospective, randomized double blinded study where patient meeting inclusion criteria for the study is divided into two groups ( Group M n=21) and ( Group P n= 21) i.e. Group M receives intravenous bolus of mephentermine 6mg and intravenous bolus of 50mcg. Hemodynamics changes in blood pressure and heart rate will monitored and compared among the study groups receiving intravenous boluses of study drugs. Data will be collected in proforma and saved by entering in the MS- EXCEL as well. Data will be analyzed using the statistical package for the social sciences (SPSS) version 27. The categorical data will be analyzed with Chi-square test and numerical variables of hemodynamic parameters between the study groups will be analyzed using student t- test. P-value \< 0.05 will be considered statistically significant. Hence, mephenterime and phenylephrine effectiveness will be studied for hemodynamic stability during cesarean section under spinal anesthesia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Mar 2023

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 31, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

March 23, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2024

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2024

Completed
Last Updated

October 9, 2024

Status Verified

October 1, 2024

Enrollment Period

1.1 years

First QC Date

January 23, 2023

Last Update Submit

October 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • To compare the intravenous bolus dose of mephentermine and phenylephrine for hemodynamic stability during elective cesarean section under spinal anesthesia

    To measure systolic blood pressure ( SBP) and diastolic blood pressure ( DBP) of the study groups

    6 months

Secondary Outcomes (2)

  • To measure Mean Arterial Pressure ( MAP ) of study groups

    6 months

  • To measure heart rate ( HR) of study group

    6 months

Study Arms (2)

Mephentermine ( M group)

EXPERIMENTAL

Group M

Drug: Intravenous bolus dose of Mephentermine and mephentermine

Phenylephrine ( P group )

EXPERIMENTAL

Group P

Drug: intravenous bolus dose of phenylephrine 50 mcg

Interventions

intravenous bolus dose of mephenteramine 6mg

Also known as: Mephentermine
Mephentermine ( M group)

intravenous bolus dose of phenylephrine 50 mcg

Also known as: Phenylephrine
Phenylephrine ( P group )

Eligibility Criteria

Age18 Years - 48 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAll parturient meeting the study inclusion criteria and receiving sub-arachnoid block for undergoing elective cesarean section at KIST MEDICAL COLLEGE AND TEACHING HOSPITAL
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patient undergoing elective cesarean section under spinal anesthesia
  • Age between 18-48 years
  • ASA class II ( all pregnant are categorized as ASA II)

You may not qualify if:

  • Patient refusal
  • Contraindication to spinal anesthesia like coagulation disorder , localized infection , sepsis, raised intracranial pressure etc
  • Patchy spinal block , failed spinal block converting to GA
  • Hypersensitivity to any drugs
  • High Risk Pregnancy ( preeclampsia, eclampsia, preterm, Gestational Diabetes , etc )

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KIST Medical and Teaching Hospital

Lalitpur, 56900, Nepal

Location

Related Publications (9)

  • Habib AS. A review of the impact of phenylephrine administration on maternal hemodynamics and maternal and neonatal outcomes in women undergoing cesarean delivery under spinal anesthesia. Anesth Analg. 2012 Feb;114(2):377-90. doi: 10.1213/ANE.0b013e3182373a3e. Epub 2011 Nov 21.

    PMID: 22104076BACKGROUND
  • Klohr S, Roth R, Hofmann T, Rossaint R, Heesen M. Definitions of hypotension after spinal anaesthesia for caesarean section: literature search and application to parturients. Acta Anaesthesiol Scand. 2010 Sep;54(8):909-21. doi: 10.1111/j.1399-6576.2010.02239.x. Epub 2010 Apr 23.

    PMID: 20455872BACKGROUND
  • Corke BC, Datta S, Ostheimer GW, Weiss JB, Alper MH. Spinal anaesthesia for Caesarean section. The influence of hypotension on neonatal outcome. Anaesthesia. 1982 Jun;37(6):658-62. doi: 10.1111/j.1365-2044.1982.tb01278.x.

    PMID: 7091625BACKGROUND
  • Ohpasanon P, Chinachoti T, Sriswasdi P, Srichu S. Prospective study of hypotension after spinal anesthesia for cesarean section at Siriraj Hospital: incidence and risk factors, Part 2. J Med Assoc Thai. 2008 May;91(5):675-80.

    PMID: 18672631BACKGROUND
  • Campagna JA, Carter C. Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology. 2003 May;98(5):1250-60. doi: 10.1097/00000542-200305000-00030. No abstract available.

    PMID: 12717149BACKGROUND
  • Mohta M, Janani SS, Sethi AK, Agarwal D, Tyagi A. Comparison of phenylephrine hydrochloride and mephentermine sulphate for prevention of post spinal hypotension. Anaesthesia. 2010 Dec;65(12):1200-5. doi: 10.1111/j.1365-2044.2010.06559.x.

    PMID: 21182601BACKGROUND
  • Mahajan L, Anand LK, Gombar KK. A randomized double-blinded comparison of ephedrine, phenylephrine and mephentermine infusions to maintain blood pressure during spinal anaesthesia for cesarean delivery: The effects on fetal acid-base status and haemodynamic control. J Anaesthesiol Clin Pharmacol. 2009;25(4):427-32.

    BACKGROUND
  • Chandak A V., Bhuyan D, Singam AP, Patil B. Comparison of bolus phenylephrine, ephedrine and mephentermine for maintenance of arterial pressure during spinal anaesthesia in caesarean section. Res J Pharm Technol. 2021;14(3):1349-52.

    BACKGROUND
  • Nag DS, Samaddar DP, Chatterjee A, Kumar H, Dembla A. Vasopressors in obstetric anesthesia: A current perspective. World J Clin Cases. 2015 Jan 16;3(1):58-64. doi: 10.12998/wjcc.v3.i1.58.

    PMID: 25610851BACKGROUND

MeSH Terms

Interventions

MephenterminePhenylephrine

Intervention Hierarchy (Ancestors)

PhentermineAmphetaminesPhenethylaminesEthylaminesAminesOrganic ChemicalsEthanolaminesAmino AlcoholsAlcohols

Study Officials

  • Dr. Smriti Koirala, MD

    KIST Medical College and Teaching Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The patients will be randomly allocated to the two groups of study by sealed envelope method. Group M patients who will receive intravenous bolus dose of mephentermine 6mg and Group P who will receive intravenous bolus dose of phenylephrine 50 mcg The drug preparations phenylephrine 50mcg/ml and mephenterime 6mg/ml will be done and labelled with code numbers by anesthesia assistant for all the patient and it is provided to anesthesiologist for administration who is not involved in the study as they will not be actively involved in the study nor in the patient care. The other anesthesia assistant or intern will be monitoring and recording information on proformas. Therefore investigator and participant of the study were blinded to the study drugs.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Comparative Interventional
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post Graduate

Study Record Dates

First Submitted

January 23, 2023

First Posted

January 31, 2023

Study Start

March 23, 2023

Primary Completion

April 29, 2024

Study Completion

May 15, 2024

Last Updated

October 9, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations